Aims To compare the efficacy and the adverse effects of levofloxacin‐containing triple
therapy, standard sequential therapy, and levofloxacin‐containing sequential therapy as first …

Objective To compare efficacy and tolerability of 7-day standard triple therapy versus 7-day
levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori (H. pylori) …

Background: Recent studies have suggested the eradication rate for Helicobacter pylori
infection with standard amoxycillin–clarithromycin‐containing triple therapy as first‐line …

Second‐line Helicobacter pylori (H. pylori) eradication with fluoroquinolone‐containing triple
therapy is one of the recommended treatment options, but neither 7‐day nor 10‐day …

Background There is growing evidence that the standard triple therapy against Helicobacter
pylori infection is losing clinical effectiveness. A triple therapy regimen with levofloxacin …

L.‐W. Chen, R.‐N. Chien, J.‐J. Chang, K.‐M. Fang and L.‐C. Chang, Comparison of the
once‐daily levofloxacin‐containing triple therapy with the twice‐daily standard triple therapy …

Background Helicobacter pylori eradication rates in Portugal are declining, due to increased
resistance of this bacterium to antimicrobial agents, especially Clarithromycin. Quadruple …

Quinolone has the disadvantage of easily acquired drug resistance. It is important to
prescribe it wisely for a high eradication rate. The current study aimed to determine the …

Background Helicobacter pylori (H. pylori) treatment remains a challenge for physicians.
Although highly effective, the standard sequential therapy fails in a certain number of …

Objective: To evaluate the efficacy of levofloxacin-based triple therapy and bismuth-based
quadruple therapy in the treatment of Helicobacter pylori (Hp) infection as rescue regimens …